FDA OKs First Liver-Directed Treatment for Metastatic Uveal Melanoma
(MedPage Today) -- The FDA announced approval of the Hepzato Kit melphalan injection system as liver-directed therapy for uveal melanoma metastases.
The approval stipulates use in adults with unresectable liver metastases that affects less than...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Eye Cancers | International Medicine & Public Health | Liver | Melanoma | Skin Cancer | Urology & Nephrology | Uveal Melanoma